Terug
Dagbereik
€ 4,23
€ 4,38
52-Weeksbereik
€ 2,71
€ 5,10
Volume
1.527.873
50D / 200D Gem.
€ 4,34
/
€ 4,10
Vorige Slotkoers
€ 4,42
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -24,8 | 0,3 |
| P/B | 10,8 | 2,9 |
| ROE % | -38,5 | 3,7 |
| Net Margin % | -237,9 | 3,8 |
| Rev Growth 5Y % | 6,4 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 8,50
+97.2%
Forward WPA
-€ 0,16
Omzet Sch.
1 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 0,34
€ 0,19 – € 0,49
|
170 M | 1 |
| FY2028 |
-€ 0,14
-€ 0,20 – -€ 0,08
|
56 M | 1 |
| FY2027 |
-€ 0,05
-€ 0,07 – -€ 0,03
|
8,8 M | 1 |
Belangrijkste Punten
Revenue grew 6,40% annually over 5 years — modest growth
Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -39,64M
PEG of 0,50 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 121,81%
Capital efficient — spends only 0,00% of revenue on capex
Groei
Revenue Growth (5Y)
6,40%
Revenue (1Y)128,21%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-38,52%
ROIC-37,01%
Net Margin-237,88%
Op. Margin-270,96%
Veiligheid
Debt / Equity
0,01
Current Ratio15,73
Interest Coverage393,40
Waardering
P/E Ratio
-24,77
P/B Ratio10,83
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 128,21% | Revenue Growth (3Y) | -11,89% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 6,40% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 14,08M | Net Income (TTM) | -33,50M |
| ROE | -38,52% | ROA | -35,41% |
| Gross Margin | 0,00% | Operating Margin | -270,96% |
| Net Margin | -237,88% | Free Cash Flow (TTM) | -39,64M |
| ROIC | -37,01% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 15,73 |
| Interest Coverage | 393,40 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -24,77 | P/B Ratio | 10,83 |
| P/S Ratio | 58,91 | PEG Ratio | 0,50 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 829,68M | Enterprise Value | 812,41M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 14,08M | 6,17M | 18,14M | 39,02M | 10,99M |
| Net Income | -33,50M | -69,92M | -72,85M | -69,46M | -76,25M |
| EPS (Diluted) | -0,17 | -0,38 | -0,44 | -0,46 | -0,73 |
| Gross Profit | 0,0 | 6,17M | 18,14M | 39,02M | 10,99M |
| Operating Income | -38,16M | -76,32M | -78,10M | -65,46M | -73,52M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 94,62M | 131,71M | 144,40M | 195,42M | 204,49M |
| Total Liabilities | 18,04M | 34,34M | 38,38M | 58,57M | 35,05M |
| Shareholders' Equity | 76,58M | 97,37M | 106,02M | 136,85M | 169,44M |
| Total Debt | 746.000,0 | 1,29M | 8,72M | 12,55M | 18,91M |
| Cash & Equivalents | 18,01M | 36,33M | 26,29M | 30,78M | 109,28M |
| Current Assets | 94,46M | 127,32M | 132,03M | 151,14M | 160,66M |
| Current Liabilities | 6,01M | 15,62M | 22,49M | 32,86M | 11,22M |